Publication: Intraoperative lidocaine infusion and 24-hour postoperative opioid consumption in obese patients undergoing laparoscopic bariatric surgery
3
Issued Date
2020-08-01
Resource Type
ISSN
18787533
15507289
15507289
Other identifier(s)
2-s2.0-85086479429
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Surgery for Obesity and Related Diseases. Vol.16, No.8 (2020), 1124-1132
Suggested Citation
Parichat Tovikkai, Stanley J. Rogers, John P. Cello, Rachel Eshima Mckay Intraoperative lidocaine infusion and 24-hour postoperative opioid consumption in obese patients undergoing laparoscopic bariatric surgery. Surgery for Obesity and Related Diseases. Vol.16, No.8 (2020), 1124-1132. doi:10.1016/j.soard.2020.04.026 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/58041
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Intraoperative lidocaine infusion and 24-hour postoperative opioid consumption in obese patients undergoing laparoscopic bariatric surgery
Abstract
© 2020 American Society for Bariatric Surgery Background: Bariatric surgery is the most effective long-term treatment for obesity. Opioid-sparing anesthesia and multimodal analgesia such as lidocaine infusion have been recommended in these patients to reduce opioid-related complications. However, evidence supporting its use for bariatric surgery population is limited. Objective: To investigate whether intraoperative lidocaine infusion is associated with decreasing opioid consumption in laparoscopic bariatric surgery. Setting: A university hospital, California, USA. Methods: In this retrospective cohort study, outcomes among consecutive obese patients undergoing laparoscopic bariatric surgery between January 2016 to December 2018 were evaluated to determine the impact of adjunctive intraoperative lidocaine infusion on 24-hour postoperative opioid consumption. Secondary outcomes, including opioid consumption during hospitalization, length of stay, and postoperative complications were determined. Post hoc analyses were performed exploring possible dose effects and drug-drug interactions. Univariable and multivariable analyses were performed to identify factors associated with opioid consumption. Results: Among 345 patients, 54 (15.7%) received intraoperative lidocaine infusion (L+) whereas 291 (84.3%) did not receive intraoperative lidocaine infusion (L−). Both L+ and L− groups shared similar demographic characteristics. The 24-hour postoperative opioid consumption was 17.6% lower in L+ (95% confidence interval −28.4 to −5.2, P = .007), but nonsignificantly lower in the multivariate model (12.8%, 95% confidence interval −24.4 to. 5, P = .06). Opioid consumption during hospitalization, length of stay, and other clinically significant outcomes did not differ. However, subgroup analysis restricted to opioid-naïve patients indicated significantly reduced opioid consumption in the L+ group. Post hoc analysis suggested interaction between lidocaine and ketamine in decreasing 24-hour postoperative opioid consumption. Conclusions: Intraoperative lidocaine infusion was not significantly associated with decreasing 24-hour postoperative opioid consumption in obese patients undergoing laparoscopic bariatric surgery.